Menzies-Gow N J, Knowles E J, Rogers I, Rendle D I
Department of Clinical Sciences and Services, Royal Veterinary College, North Mymms, Hertfordshire, UK.
Rainbow Equine Lab, Malton, North Yorkshire, UK.
Equine Vet J. 2019 Jan;51(1):33-37. doi: 10.1111/evj.12960. Epub 2018 May 17.
Circulating adiponectin concentrations were lower in ponies with a history of endocrinopathic laminitis and in nonlaminitic ponies that subsequently developed laminitis. The assays used in these studies have been discontinued or are no longer valid.
(1) to determine the validity of immunoturbidimetric (IT) and enzyme linkedimmunosorbent (ELISA) assays for equine total and high molecular weight (HMW) [adiponectin] measurement and (2) to investigate the association between [adiponectin] measured using these assays and endocrinopathic laminitis.
Method validation and cohort study.
Accuracy and precision of IT and ELISA assays for measuring total (TAC) and HMW (HMWAC) [adiponectin] were determined. Using the IT assay, the effects of anti-coagulant and storage temperature were assessed, TAC was measured in previously laminitic (PL) and never laminitic (NL) ponies (n = 6/group). Comparison with a previously validated radioimmunoassay was made in NL ponies (n = 223). Association between TAC and subsequent laminitis development in NL ponies was investigated using univariable logistic regression and ROC curve analysis.
The IT assay was precise and demonstrated good agreement with the previously validated radioimmunoassay. TAC was significantly (P<0.01) lower in PL (mean ± s.d. 8.9 ± 2.9 μg/mL) compared to NL (24.2 ± 11.8 μg/mL) ponies and in NL ponies that developed laminitis within 12 months (median 4.8 μg/mL; IQR 2.65-13.4 μg/mL) compared to those that remained nonlaminitic (19.9 μg/mL; 9.95-31.5 μg/mL). TAC was significantly (P = 0.01) associated with laminitis occurrence within 12 months. Use of the area under the ROC curve to distinguish animals that did and did not develop laminitis showed good accuracy (0.76). None of the ELISA methods validated satisfactorily.
Laminitis risk is based on data from ponies in one region.
The IT method is suitable for measurement of equine TAC. TAC is lower in ponies with previous or future laminitis. The ELISA methods are not suitable for measurement of equine HMWAC or TAC.
有内分泌性蹄叶炎病史的小马以及随后发生蹄叶炎的非蹄叶炎小马,其循环脂联素浓度较低。这些研究中使用的检测方法已停产或不再有效。
(1)确定免疫比浊法(IT)和酶联免疫吸附测定法(ELISA)用于测量马的总脂联素和高分子量(HMW)脂联素的有效性,以及(2)研究使用这些检测方法测得的脂联素与内分泌性蹄叶炎之间的关联。
方法验证和队列研究。
测定IT和ELISA检测法测量总脂联素(TAC)和HMW脂联素(HMWAC)的准确性和精密度。使用IT检测法,评估抗凝剂和储存温度的影响,测量曾患蹄叶炎(PL)和从未患蹄叶炎(NL)的小马(每组n = 6)的TAC。在NL小马(n = 223)中与先前验证的放射免疫测定法进行比较。使用单变量逻辑回归和ROC曲线分析研究NL小马中TAC与随后蹄叶炎发生之间的关联。
IT检测法精确,并且与先前验证的放射免疫测定法显示出良好的一致性。与NL小马(24.2±11.8μg/mL)相比,PL小马(平均值±标准差8.9±2.9μg/mL)的TAC显著更低(P<0.01);与未发生蹄叶炎的NL小马(19.9μg/mL;9.95 - 31.5μg/mL)相比,在12个月内发生蹄叶炎的NL小马的TAC中位数为4.8μg/mL(IQR 2.65 - 13.4μg/mL)。TAC与12个月内蹄叶炎的发生显著相关(P = 0.01)。使用ROC曲线下面积来区分发生和未发生蹄叶炎的动物显示出良好的准确性(0.76)。没有一种ELISA方法得到令人满意的验证。
蹄叶炎风险基于一个地区小马的数据。
IT方法适用于测量马的TAC。曾患或将会患蹄叶炎的小马的TAC较低。ELISA方法不适用于测量马的HMWAC或TAC。